Telix Pharmaceuticals Limited American Depositary Receipt (TLX)
Market Closed
27 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XFRA $
9. 98
-0.24
-2.3483%
$
3.5B Market Cap
- P/E Ratio
- Div Yield
106,243 Volume
- Eps
$ 10.22
Previous Close 
Want to track TLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Telix Pharmaceuticals Limited American Depositary Receipt (TLX) Statistics
Valuation metrics
Market Cap 3.5B
Enterprise value 5.45B
Trailing P/E (ttm) -456.7
Forward P/E -
PEG ratio 3.76
Price/Sales (ttm) 4.06
Price/Book (mrq) 7.97
Enterprise Value/Revenue 4.46
Enterprise Value/EBITDA 147.04
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 141.02K
Average volume (90 days) 140.38K
Price summary
52-Week low 6.28
52-Week high 14.27
Beta -
50-Day moving average 10.26
200-Day moving average 8.82
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.01%
Operating margin 0.02%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.61
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.63
Total debt (mrq) -
Total Debt/Equity (mrq) 1.12
Current ratio (mrq) 1.43%
Book value per share (mrq) 1.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
